Dr. Amar Gajjar, MD
Claim this profileSt. Jude Children's Research Hospital
Studies Brain Tumor
Studies Brain Cancer
11 reported clinical trials
20 drugs studied
Area of expertise
1Brain Tumor
H3.3K27M positive
H3F3A
IDH positive
2Brain Cancer
IDH positive
BRAF negative
Stage I
Affiliated Hospitals
Clinical Trials Amar Gajjar, MD is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
PARP Inhibitor + Temozolomide
for Brain Cancer
This trial studies the safety and best dose of BGB-290 and temozolomide in treating young people with a specific type of brain tumor. BGB-290 blocks enzymes needed for tumor growth, while temozolomide kills or stops cancer cells from growing. The goal is to find out if this combination works better for these patients.
Recruiting1 award Phase 1
More about Amar Gajjar, MD
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Amar Gajjar, MD has experience with
- Dabrafenib
- Trametinib
- Alisertib
- Cisplatin
- Craniospinal Irradiation With Boost To The Primary Tumor Site
- Cyclophosphamide
Breakdown of trials Amar Gajjar, MD has run
Brain Tumor
Brain Cancer
Glioblastoma
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amar Gajjar, MD specialize in?
Amar Gajjar, MD focuses on Brain Tumor and Brain Cancer. In particular, much of their work with Brain Tumor has involved H3.3K27M positive patients, or patients who are H3F3A.
Is Amar Gajjar, MD currently recruiting for clinical trials?
Yes, Amar Gajjar, MD is currently recruiting for 2 clinical trials in Memphis Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Amar Gajjar, MD has studied deeply?
Yes, Amar Gajjar, MD has studied treatments such as Dabrafenib, Trametinib, Alisertib.
What is the best way to schedule an appointment with Amar Gajjar, MD?
Apply for one of the trials that Amar Gajjar, MD is conducting.
What is the office address of Amar Gajjar, MD?
The office of Amar Gajjar, MD is located at: St. Jude Children's Research Hospital, Memphis, Tennessee 38105 United States. This is the address for their practice at the St. Jude Children's Research Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.